Revenue from contracts with customers

6 Months Ended

Jun. 30, 2024

Revenue from Contract with Customer [Abstract]

Revenue from contracts with customers

Note 4 – Revenue from contracts with customers

Disaggregated revenue

The Company provided diagnostic test products and laboratory services to hospitals, clinical laboratories and other healthcare providing customers, and entered into collaboration agreements with government agencies, non-governmental organizations, and healthcare providers. The revenues by type of service consist of the following:

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Product sales	$	28,000	$	439,672	$	169,373	$	850,569
Laboratory services		-		44,003		26,776		65,676
Collaboration revenue		-		252,462		-		733,336
Total revenue	$	28,000	$	736,137	$	196,149	$	1,649,581

Revenues by geography are as follows:

	Three Months Ended June 30,				Six Months Ended June 30,
	2024		2023		2024		2023
Domestic	$	28,000	$	266,313	$	196,149	$	381,262
International		-		469,824		-		1,268,319
Total revenue	$	28,000	$	736,137	$	196,149	$	1,649,581

Deferred revenue

Changes to deferred revenue for the periods were as follows:

Balance at December 31, 2022	$	142,061
Contracts with customers		74,109
Recognized in the current period		(144,196	)
Currency translation adjustment		(46,048	)
Balance at December 31, 2023		25,926
Recognized in the current period		(21,096	)
Refunded to customers in the current period		(4,830	)
Balance at June 30, 2024	$	-